Tony Frial
About Tony Frial
Tony Frial is the Director of Market Access Strategy & Marketing at Alkermes, with extensive experience in the pharmaceutical industry, particularly in market access and healthcare solutions.
Current Role at Alkermes
Tony Frial is the Director of Market Access Strategy & Marketing at Alkermes in Boston, Massachusetts. Since July 2021, he has led the Market Access Strategy and Marketing for Alkermes' CNS and Addiction portfolio, which includes products like LYBALVI, ARISTADA, and VIVITROL. Tony also oversees market access strategy for Institutional Accounts, Federal, and GPO/Trade channels.
Previous Roles at AstraZeneca
Tony Frial has a substantial history with AstraZeneca, having held multiple roles in their Toronto, Canada Area office. He served as Senior Manager, Healthcare Solutions, and Marketing Manager for Crestor & Atacand from 2008 to 2011. Prior to that, he was the Manager of CV Reimbursement from 2006 to 2008, Medical Sales Representative from 2002 to 2006, and Sales Planning Analyst from 2000 to 2002.
Education and Background
Tony Frial completed a Full Time MBA Program at the University of Edinburgh Business School, focusing on Strategic Management, Marketing, and International Business, and earned a Master of Business Administration (M.B.A.), from 1998 to 1999. He also holds a Bachelor's Degree from the University of Toronto.
Expertise in Market Access and Healthcare Solutions
Tony Frial possesses extensive experience in the pharmaceutical industry, particularly in market access and healthcare solutions. His expertise includes directing market access strategy, oversight of multiple channels such as Institutional Accounts, Federal, and GPO/Trade, along with a robust background in product-specific marketing for CNS and Addiction portfolios.